5151 - 5160 of 8620 Results
Title
Year
-
RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 16
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5797696Citation Count: 58
- A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively2022OPENTitle: A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, RespectivelyJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 6Start Page: 1018End Page: 1018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11061018Best OA location URL: https://www.mdpi.com/2073-4409/11/6/1018/pdf?version=1647518110Citation Count: 4
- Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputation2024OPENTitle: Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae146/57311805/fcae146.pdfCitation Count: 1
-
OPENTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participantsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000680Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7057071Citation Count: 23
-
OPENTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 13
-
OPENTitle: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell FunctionJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009Best OA location URL: http://www.cell.com/article/S2162253120301359/pdfCitation Count: 11
- A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid2016OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 5
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 23
-
OPENTitle: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 363Issue #:Start Page: 114370End Page: 114370Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370Best OA location URL: https://doi.org/10.1016/j.expneurol.2023.114370Citation Count: 9